370 related articles for article (PubMed ID: 28386257)
1. The Other Function: Class II-Restricted Antigen Presentation by B Cells.
Adler LN; Jiang W; Bhamidipati K; Millican M; Macaubas C; Hung SC; Mellins ED
Front Immunol; 2017; 8():319. PubMed ID: 28386257
[TBL] [Abstract][Full Text] [Related]
2. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
3. Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.
Schlundt A; Günther S; Sticht J; Wieczorek M; Roske Y; Heinemann U; Freund C
J Mol Biol; 2012 Oct; 423(3):294-302. PubMed ID: 22820093
[TBL] [Abstract][Full Text] [Related]
4. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
6. Studying MHC Class II Presentation of Immobilized Antigen by B Lymphocytes.
Sáez JJ; Lennon-Duménil AM; Yuseff MI
Methods Mol Biol; 2019; 1988():419-437. PubMed ID: 31147956
[TBL] [Abstract][Full Text] [Related]
7. Synergy between B cell receptor/antigen uptake and MHCII peptide editing relies on HLA-DO tuning.
Jiang W; Adler LN; Macmillan H; Mellins ED
Sci Rep; 2019 Sep; 9(1):13877. PubMed ID: 31554902
[TBL] [Abstract][Full Text] [Related]
8. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
9. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
10. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
11. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
12. B cells rapidly target antigen and surface-derived MHCII into peripheral degradative compartments.
Hernández-Pérez S; Vainio M; Kuokkanen E; Šuštar V; Petrov P; Forstén S; Paavola V; Rajala J; Awoniyi LO; Sarapulov AV; Vihinen H; Jokitalo E; Bruckbauer A; Mattila PK
J Cell Sci; 2019 Dec; 133(5):. PubMed ID: 31780582
[TBL] [Abstract][Full Text] [Related]
13. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
14. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
[TBL] [Abstract][Full Text] [Related]
15. The immunobiology of ubiquitin-dependent B cell receptor functions.
Drake JR
Mol Immunol; 2018 Sep; 101():146-154. PubMed ID: 29940407
[TBL] [Abstract][Full Text] [Related]
16. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
17. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
18. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
19. HLA-DMA polymorphisms differentially affect MHC class II peptide loading.
Álvaro-Benito M; Wieczorek M; Sticht J; Kipar C; Freund C
J Immunol; 2015 Jan; 194(2):803-16. PubMed ID: 25505276
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-mediated fluctuations in MHC class II facilitate efficient germinal center B cell responses.
Bannard O; McGowan SJ; Ersching J; Ishido S; Victora GD; Shin JS; Cyster JG
J Exp Med; 2016 May; 213(6):993-1009. PubMed ID: 27162138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
